![Philip L. Smith](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Philip L. Smith
Direktor/Vorstandsmitglied bei
REDPOINT BIO CORPORATION
Profil
Philip L.
Smith is currently a Director at Linguagen Corp., Trinity Biosystems, Inc., and Mid-Atlantic Capital Alliance.
Previously, he held positions as a Director at Robcor Properties, Inc., GlaxoSmithKline Pharmaceuticals Ltd., Dr. Reddy's Research & Development BV, Avantium Technologies BV, Onyvax Ltd., and GSK Equity Investments Ltd. He has also pursued his education, earning graduate and doctorate degrees from Northeastern University and an undergraduate degree from the University of Maine.
Aktive Positionen von Philip L. Smith
| Unternehmen | Position | Beginn |
|---|---|---|
| REDPOINT BIO CORPORATION | Direktor/Vorstandsmitglied | - |
Mid-Atlantic Capital Alliance | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Philip L. Smith
| Unternehmen | Position | Ende |
|---|---|---|
Dr. Reddy's Research & Development BV
 Dr. Reddy's Research & Development BV Pharmaceuticals: MajorHealth Technology Develops injectable formulations and drugs | Direktor/Vorstandsmitglied | 12.05.2010 |
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity invests in companies located in the United States and United kingdom. The firm targets companies operating in the field of biotechnology sector. It provides financing for early stage capital requirements. | Private Equity Investor | 31.01.2009 |
Robcor Properties, Inc.
 Robcor Properties, Inc. Real Estate DevelopmentFinance Owns and leases industrial buildings | Direktor/Vorstandsmitglied | 05.07.2007 |
| GLAXOSMITHKLINE PHARMACEUTICALS LIMITED | Corporate Officer/Principal | 01.06.2002 |
Avantium Technologies BV
 Avantium Technologies BV Chemicals: SpecialtyProcess Industries Manufactures recyclable polymers | Direktor/Vorstandsmitglied | - |
Ausbildung von Philip L. Smith
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
42
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Robcor Properties, Inc.
Robcor Properties, Inc. Real Estate DevelopmentFinance Owns and leases industrial buildings | Finance |
GSK Equity Investments Ltd.
GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity invests in companies located in the United States and United kingdom. The firm targets companies operating in the field of biotechnology sector. It provides financing for early stage capital requirements. | Finance |
GlaxoSmithKline Pharmaceuticals Ltd.
 GlaxoSmithKline Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Engages in the business of manufacturing, distributing and trading in pharmaceuticals | Health Technology |
Dr. Reddy's Research & Development BV
Dr. Reddy's Research & Development BV Pharmaceuticals: MajorHealth Technology Develops injectable formulations and drugs | Health Technology |
Avantium Technologies BV
Avantium Technologies BV Chemicals: SpecialtyProcess Industries Manufactures recyclable polymers | Process Industries |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Maine
 University of Maine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Onyvax Ltd.
 Onyvax Ltd. Miscellaneous Commercial ServicesCommercial Services Develops cancer remedy therapies | Commercial Services |
Linguagen Corp.
 Linguagen Corp. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in the field of flavor discovery & modification | Commercial Services |
Trinity Biosystems, Inc.
 Trinity Biosystems, Inc. Pharmaceuticals: MajorHealth Technology Develops and formulates orally delivered bio-therapeutic macromolecules | Health Technology |
Mid-Atlantic Capital Alliance |
